Editorial standards & AI policy

What we publish

Every briefing follows the same structure — the signal, why it matters, what changed, who it affects, what to watch next, the NPHLA takeaway and a numbered Source File — so readers can always see what is fact, what is interpretation and where each fact comes from.

When nothing meaningful has happened, we do not manufacture news. Quiet days carry the automated “What Changed Today” record summaries and evergreen formats such as explainers and primers, clearly labelled as such.

Sources and copyright

• Official records come first: the FDA, the Federal Register, ClinicalTrials.gov, PubMed and other primary sources.
• We never scrape and rewrite another publication’s article. Industry and news coverage contributes headlines and links only, used to see what the industry is discussing and to corroborate.
• Only U.S. government (public-domain) text is ever quoted, and always with attribution.
• Source types are labelled on every briefing: primary source, official notice, peer reviewed, industry report, company announcement, news reporting, expert commentary.
• Where credible sources disagree, the briefing says so rather than picking a side silently.

How AI is used

NPHLA uses AI as an assistant, never as an author or an expert. Briefings marked AI-assisted were drafted by a language model working only from the sources in the Source File, under versioned instructions (current version: intel-briefing@2026-10-01.1) that forbid unsupported claims, dosing advice and close paraphrase. AI-assisted and automated briefings are never credited to an individual. Pieces written by NPHLA staff or approved contributors carry the writer’s name, credentials and disclosures, and a named expert appears on an AI-assisted briefing only as its reviewer (see our editorial standards).

• Human review. By default every AI-assisted draft is reviewed by an NPHLA editor before publication. Drafts touching drug safety, dosing, treatment recommendations, legal or regulatory interpretation, scope of practice, experimental therapies, adverse events or named businesses are always reviewed.
• Automated record summaries. “What Changed Today” digests are compiled automatically from official records. They state what each record says, link to it and add no interpretation.
• Signal strength describes how much attention a topic is drawing across the sources we track. It is not a measure of medical certainty, quality of evidence or importance to any individual.
• Artwork. Illustrations generated with AI (visual system nphla-visual@2026-10-01.1) are abstract by design: no realistic people, no depictions of real events, no text. They are approved by staff before use and never presented as photographs.

Corrections and updates

Published briefings are never silently rewritten. When a developing story changes, an editor approves the update and it is recorded on the briefing’s public update timeline. Substantive errors are corrected openly, with a dated correction note. To report an error, contact the editorial team.

Professional information, not advice

NPHLA Intelligence is information for professionals. It is not medical, legal or regulatory advice for any individual or organisation. State-level information shows its jurisdiction, source and the date it was last verified. Therapies in clinical trials are investigational, and device clearances are not approvals.

Privacy

Reading Intelligence requires no account. We count views, reads and shares only as anonymous daily totals, and we honour Global Privacy Control and Do Not Track. What members follow is private to them and used only to tailor their own feed and emails. Privacy choices.